Torasemid in the treatment of cardiovascular disease: the optimal use in conditions of comorbidity
| Autor: | N. G. Poteshkina, A.A. Troshina |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
lcsh:Diseases of the circulatory (Cardiovascular) system
medicine.medical_specialty hypertension business.industry medicine.drug_class medicine.medical_treatment diuver heart failure Disease torasemid Loop diuretic medicine.disease Comorbidity lcsh:RC666-701 Heart failure medicine In patient Diuretic business Intensive care medicine |
| Zdroj: | Системные гипертензии, Vol 12, Iss 4, Pp 38-41 (2015) |
| ISSN: | 2542-2189 2075-082X |
| DOI: | 10.26442/2075-082x_12.4.38-41 |
| Popis: | The article reviews the current clinical data on the use of one of the modern pharmacological drugs torasemide (Diuver, Teva Pharmaceutical Industries Ltd., Israel) in the treatment of cardiovascular disease in conditions of comorbidity. Presents a comprehensive view of the problem identified and a reasoned approach to the choice of diuretic therapy with clinico-pathophysiological substantiation of the use of a loop diuretic torasemid. Conceptually formed of a number of provisions on the application of one of the modern diuretic drugs in therapeutic practice in patients with arterial hypertension and heart failure. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|